Andres Gonzalez-Jimenez

Dr. Andres Gonzalez-Jimenez


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2014 in Gastroenterology
Verified
Journal Article
Closed access
MRMercedes Robles-Diaz
Mercedes Robles-Diaz
Mª Isabel LucenaMª Isabel Lucena
Mª Isabel Lucena
NKNeil Kaplowitz
Neil Kaplowitz
CSCamilla Stephens
Camilla Stephens
IMInmaculada Medina–Cáliz
Inmaculada Medina–Cáliz
RARaul J. Andrade
Raul J. Andrade

1 July 2021 in Journal of Hepatology
Verified
Journal Article
Open access
CSCamilla Stephens
Camilla Stephens
MRMercedes Robles-Diaz
Mercedes Robles-Diaz
IMInmaculada Medina-Caliz
Inmaculada Medina-Caliz
MGMiren Garcia-Cortes
Miren Garcia-Cortes
AOAida Ortega-Alonso
Aida Ortega-Alonso
PCParticipating Clinical Centres
Participating Clinical Centres
Prospective drug-induced liver injury (DILI) registries are important sources of information on idiosyncratic DILI. We aimed to present a comprehensive analysis of 843 patients with DILI enrolled into the Spanish DILI Registry over a 20-year time period. Cases were identified, diagnosed and followed prospectively. Clinical features, drug information and outcome data were collected. A total of 843 patients, with a mean age of 54 years (48% females), were enrolled up to 2018. Hepatocellular injury was associated with younger age (adjusted odds ratio [aOR] per year 0.983; 95% CI 0.974-0.991) and lower platelet count (aOR per unit 0.996; 95% CI 0.994-0.998). Anti-infectives were the most common causative drug class (40%). Liver-related mortality was more frequent in patients with hepatocellular damage aged ≥65 years (p = 0.0083) and in patients with underlying liver disease (p = 0.0221). Independent predictors of liver-related death/transplantation included nR-based hepatocellular injury, female sex, higher onset aspartate aminotransferase (AST) and bilirubin values. nR-based hepatocellular injury was not associated with 6-month overall mortality, for which comorbidity burden played a more important role. The prognostic capacity of Hy's law varied between causative agents. Empirical therapy (corticosteroids, ursodeoxycholic acid and MARS) was prescribed to 20% of patients. Drug-induced autoimmune hepatitis patients (26 cases) were mainly females (62%) with hepatocellular damage (92%), who more frequently received immunosuppressive therapy (58%). AST elevation at onset is a strong predictor of poor outcome and should be routinely assessed in DILI evaluation. Mortality is higher in older patients with hepatocellular damage and patients with underlying hepatic conditions. The Spanish DILI Registry is a valuable tool in the identification of causative drugs, clinical signatures and prognostic risk factors in DILI and can aid physicians in DILI characterisation and management. Clinical information on drug-induced liver injury (DILI) collected from enrolled patients in the Spanish DILI Registry can guide physicians in the decision-making process. We have found that older patients with hepatocellular type liver injury and patients with additional liver conditions are at a higher risk of mortality. The type of liver injury, patient sex and analytical values of aspartate aminotransferase and total bilirubin can also help predict clinical outcomes.

1 September 2016 in Journal of Hepatology
Verified
Journal Article
Closed access
IMInmaculada Medina-Caliz
Inmaculada Medina-Caliz
MRMercedes Robles-Diaz
Mercedes Robles-Diaz
BGBeatriz Garcia-Muñoz
Beatriz Garcia-Muñoz
CSCamilla Stephens
Camilla Stephens
AOAida Ortega-Alonso
Aida Ortega-Alonso
RARaul J. Andrade
Raul J. Andrade

13 November 2014 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Open access
PDF file
MRMercedes Robles-Diaz
Mercedes Robles-Diaz
AGAndres Gonzalez-Jimenez
Andres Gonzalez-Jimenez
IMI. Medina‐Caliz
I. Medina‐Caliz
CSC. Stephens
C. Stephens
MGMiren Garcia-Cortes
Miren Garcia-Cortes
TNthe SLatinDILI Network
the SLatinDILI Network
Summary: Background: We have observed an increase in hepatotoxicity (DILI) reporting related to the use of anabolic androgenic steroids (AAS) for bodybuilding.Aim: To characterise phenotype presentation, outcome and severity of AAS DILI.Methods: Data on 25 cases of AAS DILI reported to the Spanish (20) and Latin‐American (5) DILI Registries were collated and compared with previously published cases.Results: AAS DILI increased from representing less than 1% of the total cases in the Spanish DILI Registry in the period 2001–2009 to 8% in 2010–2013. Young men (mean age 32 years), requiring hospitalisation, hepatocellular injury and jaundice were predominating features among the AAS cases. AAS DILI caused significantly higher bilirubin values independent of type of damage when compared to other drug classes (P = 0.001). Furthermore, the cholestatic AAS cases presented significantly higher mean peak bilirubin (P = 0.029) and serum creatinine values (P = 0.0002), compared to the hepatocellular cases. In a logistic regression model, the interaction between peak bilirubin values and cholestatic damage was associated with the development of AAS‐induced acute kidney impairment (AKI) [OR 1.26 (95% CI: 1.035–1.526); P = 0.021], with 21.5 ×ULN being the best bilirubin cut‐off point for predicting AKI risk (AUCROC 0.92). No fatalities occurred.Conclusions: Illicit recreational AAS use is a growing cause of reported DILI that can lead to severe hepatic and renal injury. AAS DILI is associated with a distinct phenotype, characterised by considerable bilirubin elevations independent of type of damage. Although hepatocellular injury predominates, acute kidney injury develops in cholestatic cases with pronounced jaundice.

1 September 2018 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
IMInmaculada Medina-Caliz
Inmaculada Medina-Caliz
MGMiren Garcia-Cortes
Miren Garcia-Cortes
AGAndres Gonzalez-Jimenez
Andres Gonzalez-Jimenez
MCMaria R. Cabello
Maria R. Cabello
MRMercedes Robles-Diaz
Mercedes Robles-Diaz
RRR Ruíz
R Ruíz

24 March 2015 in Liver International
Verified
Journal Article
Closed access
PDF file
MRMercedes Robles-Diaz
Mercedes Robles-Diaz
MGMiren Garcia-Cortes
Miren Garcia-Cortes
IMInmaculada Medina‐Caliz
Inmaculada Medina‐Caliz
AGAndres Gonzalez-Jimenez
Andres Gonzalez-Jimenez
RGRocio Gonzalez‐Grande
Rocio Gonzalez‐Grande
TCthe Spanish DILI Registry and Faster Evidence‐based Translation (SAFE‐T) Consortium
the Spanish DILI Registry and Faster Evidence‐based Translation (SAFE‐T) Consortium